News & Perspective

May 18, 2011

May 18, 2011

Experts: Regulatory issues are main reason for keeping smallpox virus

(CIDRAP News) – When the World Health Assembly (WHA) considers the fate of the remaining stocks of smallpox virus this week, the debate is likely to be framed in part by a report from a group of independent experts that says the only strong reason for keeping the virus is to satisfy strict regulatory requirements for new vaccines and antivirals.

Oct 28, 2010

Oct 28, 2010

CDC sees smooth road so far for flu vaccine

(CIDRAP News) – In a flu vaccine update at a federal advisory meeting today, officials with the US Centers for Disease Control and Prevention (CDC) said early signs suggest flu vaccine uptake in children is on par with last year and that enhanced monitoring for narcolepsy and seizures has turned up no signals of trouble.

Oct 13, 2010

Oct 13, 2010

H3N2 a player in early Northern Hemisphere flu season

(CIDRAP News) – More signals suggest the Southern Hemisphere's flu season is winding down, while activity is low at the start of the Northern Hemisphere's flu season, except in China, which is seeing moderate H3N2 circulation.

May 14, 2010

May 14, 2010

Surveillance reports show few pandemic flu hot spots

(CIDRAP News) – Low levels of flu activity across the United States resemble a summer pattern, while globally only sporadic pandemic flu activity is occurring with the most active areas in parts of the Caribbean and Central America, according to updates today.

Oct 31, 2008

Oct 31, 2008

Encouraging results reported for injectable flu drug

(CIDRAP News) – BioCryst Pharmaceuticals Inc. reported encouraging results this week in two phase 2 trials of its injectable antiviral drug, peramivir, a potential new treatment for influenza.

Peramivir is a neuraminidase inhibitor, like the licensed antivirals oseltamivir (Tamiflu), which is taken orally, and zanamivir (Relenza), inhaled as a powder.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»